|
|
||||||||




Departments of
*
Medicine,
Immunology, and
Pathology, Duke University Medical Center, Durham, NC 27710; and
§
Department of Medicine, University of Texas Southwestern School of Medicine, Dallas, TX 75235
The roles that thymus cytokines might play in regulating thymic
atrophy are not known. Reversing thymic atrophy is important for immune
reconstitution in adults. We have studied cytokine mRNA steady-state
levels in 45 normal human (aged 3 days to 78 years) and 34 myasthenia
gravis thymuses (aged 4 to 75 years) during aging, and correlated
cytokine mRNA levels with thymic signal joint (sj) TCR
excision
circle (TREC) levels, a molecular marker for active thymopoiesis. LIF,
oncostatin M (OSM), IL-6, M-CSF, and stem cell factor (SCF) mRNA were
elevated in normal and myasthenia gravis-aged thymuses, and correlated
with decreased levels of thymopoiesis, as determined by either
decreased keratin-positive thymic epithelial space or decreased thymic
sjTRECs. IL-7 is a key cytokine required during the early stages of
thymocyte development. Interestingly, IL-7 mRNA expression did not fall
with aging in either normal or myasthenia gravis thymuses. In vivo
administration of LIF, OSM, IL-6, or SCF, but not M-CSF, i.p. to mice
over 3 days induced thymic atrophy with loss of CD4+,
CD8+ cortical thymocytes. Taken together, these data
suggest a role for thymic cytokines in the process of thymic
atrophy.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |